SEC Form 4 · accession 0001104659-15-044741
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Steele Jr. M.D. Ph.D.
Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 6:35 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $53.90 | Jun 10, 2015 | A | 20,000 | A | — | Jun 9, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option award vests over three years in equal increments upon each anniversary of the date of grant. Granted upon the election of the Reporting Person as non-employee director of the Issuer.